Healthcare

Study Links Head Injuries to Increased Brain Cancer Risk, Driving Treatment Research

Study Links Head Injuries to Increased Brain Cancer Risk, Driving Treatment Research

A Mass General Brigham study of 75,000 patients reveals traumatic brain injuries elevate malignant brain tumor risk, highlighting the importance of ongoing treatment development by companies like CNS Pharmaceuticals Inc.

September 2, 2025
Annovis Bio CEO to Present at H.C. Wainwright Global Investment Conference

Annovis Bio CEO to Present at H.C. Wainwright Global Investment Conference

Annovis Bio's CEO will present at the H.C. Wainwright conference, highlighting the company's focus on developing innovative therapies for neurodegenerative diseases like Alzheimer's and Parkinson's.

September 2, 2025
Cybin Appoints Co-Founder Eric So as Interim CEO Following Drysdale's Departure

Cybin Appoints Co-Founder Eric So as Interim CEO Following Drysdale's Departure

Cybin Inc. has appointed co-founder Eric So as interim CEO following Doug Drysdale's resignation, a leadership transition that comes as the company advances its late-stage psychedelic-based treatments for mental health disorders.

September 2, 2025
SoulCycle Master Instructor Julie Dermer Shares Insights on Fitness Industry Evolution and Personal Growth

SoulCycle Master Instructor Julie Dermer Shares Insights on Fitness Industry Evolution and Personal Growth

Julie Dermer's journey from SoulCycle rider to master instructor at age 40 demonstrates how the fitness industry values authenticity and personal evolution, highlighting broader trends in wellness career paths and professional reinvention.

September 2, 2025
West Baltimore Renaissance Foundation Channels State Funding to Address Community Needs Through Strategic Partnerships

West Baltimore Renaissance Foundation Channels State Funding to Address Community Needs Through Strategic Partnerships

The West Baltimore Renaissance Foundation is leveraging Maryland Health Services Cost Review Commission funding to implement critical community programs addressing workforce development, youth mentoring, food access, and population health through its newly established opportunity center.

September 2, 2025
Scinai Immunotherapeutics Reports Strong First-Half 2025 Results with Revenue Growth and Improved Cash Position

Scinai Immunotherapeutics Reports Strong First-Half 2025 Results with Revenue Growth and Improved Cash Position

Scinai Immunotherapeutics demonstrated significant financial improvement in the first half of 2025, with revenue growth, reduced losses, and strengthened liquidity, positioning the company for continued advancement of its anti-IL-17 NanoAb program and CDMO business expansion.

September 2, 2025
Atlanta Community Food Bank Mobilizes Community During Hunger Action Month as Food Insecurity Reaches Decade High

Atlanta Community Food Bank Mobilizes Community During Hunger Action Month as Food Insecurity Reaches Decade High

The Atlanta Community Food Bank is leading a community-wide mobilization effort during Hunger Action Month to address record food insecurity levels exacerbated by recent federal program cuts, with 1 in 7 Georgians and 1 in 5 children facing hunger.

September 2, 2025
Calidi Biotherapeutics to Present RedTail Platform at H.C. Wainwright Global Investment Conference

Calidi Biotherapeutics to Present RedTail Platform at H.C. Wainwright Global Investment Conference

Calidi Biotherapeutics will showcase its innovative RedTail platform at the H.C. Wainwright conference, highlighting its potential to revolutionize cancer treatment through systemic delivery of genetic medicines to metastatic sites.

September 2, 2025
NFL PLAY 60 and Kids Heart Challenge Partner to Enhance Student Physical Activity and Mental Wellness

NFL PLAY 60 and Kids Heart Challenge Partner to Enhance Student Physical Activity and Mental Wellness

The American Heart Association and NFL are expanding their NFL PLAY 60 program in collaboration with Kids Heart Challenge to promote physical activity and mental wellness among students, offering new resources including family challenges, CPR training with Super Bowl ticket incentives, and school grants.

September 2, 2025
Hippos Expands Cannabis Wellness Line with Three New Tinctures Targeting Energy, Stress, and Sleep

Hippos Expands Cannabis Wellness Line with Three New Tinctures Targeting Energy, Stress, and Sleep

Missouri-based Hippos Cannabis has expanded its award-winning Hugs wellness line with three new cannabis tinctures designed for daytime energy, stress relief, and nighttime sleep, reflecting the growing consumer demand for targeted plant-based wellness solutions.

September 2, 2025
Maryland Faces Economic and Healthcare Challenges Amid Recession Warning

Maryland Faces Economic and Healthcare Challenges Amid Recession Warning

Maryland confronts significant economic vulnerability with a high recession risk, potential Medicare Advantage plan disruptions, and ongoing infrastructure recovery while navigating political and administrative tensions.

September 2, 2025
Sasha Moore Awarded 2025 Truth, Justice, and Fairness Scholarship for MBA Pursuit in Healthcare

Sasha Moore Awarded 2025 Truth, Justice, and Fairness Scholarship for MBA Pursuit in Healthcare

Sasha Moore receives the 2025 Siegfried & Jensen Truth, Justice, and Fairness Scholarship to complete her MBA at Western Governors University, aiming to improve support systems for accident victims through her healthcare career.

September 2, 2025
Maryland's Medicare Advantage Crisis Threatens Coverage for Thousands of Seniors

Maryland's Medicare Advantage Crisis Threatens Coverage for Thousands of Seniors

Maryland's unique hospital payment system and the elimination of state grants are forcing major insurance providers to consider withdrawing Medicare Advantage plans, potentially disrupting healthcare coverage for tens of thousands of retirees who rely on supplemental benefits.

August 31, 2025
CD BioGlyco Expands Glycobiology Research Capabilities with Custom Glycoconjugate Synthesis Service

CD BioGlyco Expands Glycobiology Research Capabilities with Custom Glycoconjugate Synthesis Service

CD BioGlyco's new custom glycoconjugate synthesis service enables researchers to study glycan functions in cell recognition and immune responses, advancing biomedical research capabilities.

August 31, 2025
Former Young Caregiver Omarion Calloway Releases Free Guide to Support Millions of Hidden Child Caregivers

Former Young Caregiver Omarion Calloway Releases Free Guide to Support Millions of Hidden Child Caregivers

Omarion Calloway's 'More Than Survival' guide addresses the critical needs of over 5.4 million young caregivers in the U.S., offering practical support and advocating for systemic change in healthcare and education systems.

August 31, 2025
Creative Biolabs Advances Biopharmaceutical Innovation Through Glycobiology Expertise

Creative Biolabs Advances Biopharmaceutical Innovation Through Glycobiology Expertise

Creative Biolabs is enhancing biopharmaceutical development through advanced glycoprotein engineering and polysaccharide analysis technologies that improve drug efficacy, safety, and stability.

August 30, 2025
Dr. Susan Littman's 'Picture of Health' Web Series Returns with Episode 2, Secures Season Two Renewal

Dr. Susan Littman's 'Picture of Health' Web Series Returns with Episode 2, Secures Season Two Renewal

Dr. Susan Littman's acclaimed medical web series returns after a two-year hiatus with a visually stunning second episode that examines how post-COVID technological advances and evolving patient expectations are reshaping healthcare, while also announcing renewal for a second season to further explore medicine's rapidly changing landscape.

August 29, 2025
Major Health Care Companies Face Bankruptcy Amid Sector-Wide Financial Crisis

Major Health Care Companies Face Bankruptcy Amid Sector-Wide Financial Crisis

The health care sector is experiencing an alarming wave of bankruptcies among major players, including minority-serving firms like Astiva Health, as financial pressures threaten the stability of the entire industry.

August 29, 2025
Clene Inc. Advances Neurodegenerative Disease Treatment CNM-Au8® Toward Potential FDA Accelerated Approval

Clene Inc. Advances Neurodegenerative Disease Treatment CNM-Au8® Toward Potential FDA Accelerated Approval

Clene Inc. is progressing its oral treatment CNM-Au8® for ALS and multiple sclerosis through late-stage clinical development, with key FDA meetings and regulatory catalysts potentially accelerating commercialization for patients with limited treatment options.

August 29, 2025
Zevra Therapeutics to Present New MIPLYFFA Data at International Congress, Including Best Poster Award Winner

Zevra Therapeutics to Present New MIPLYFFA Data at International Congress, Including Best Poster Award Winner

Zevra Therapeutics will present four posters on MIPLYFFA (arimoclomol) at the International Congress of Inborn Errors of Metabolism, including a Best Poster award-winning presentation detailing its mechanism of action for treating Niemann-Pick disease type C, highlighting significant advancements in rare disease treatment.

August 29, 2025
Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Treatment Development

Propanc Biopharma Secures $4 Million in Public Offering to Advance Cancer Treatment Development

Propanc Biopharma has closed a $4 million public offering to fund development of its novel pancreatic proenzyme therapy targeting cancer stem cells in pancreatic, ovarian, and colorectal cancers.

August 29, 2025
Raising Relief Foundation to Host Denim and Diamonds Gala to Fund Critical Community Support Programs

Raising Relief Foundation to Host Denim and Diamonds Gala to Fund Critical Community Support Programs

The Raising Relief Foundation's upcoming Denim and Diamonds Gala on November 15, 2025, aims to replenish essential funding for community initiatives including support for Gold Star families, foster children, suicide counseling, and domestic violence therapy following last year's cancellation.

August 29, 2025
ABVC BioPharma Receives $450,000 in Q3 Licensing Payments from OncoX Partnership

ABVC BioPharma Receives $450,000 in Q3 Licensing Payments from OncoX Partnership

ABVC BioPharma's receipt of $450,000 in licensing payments from OncoX BioPharma highlights the financial strength of their oncology partnership and positions the company to capitalize on the growing $469 billion cancer therapeutics market.

August 29, 2025
North Atlanta Injury Law Provides Critical Guidance on Post-Accident Procedures for Georgia Drivers

North Atlanta Injury Law Provides Critical Guidance on Post-Accident Procedures for Georgia Drivers

North Atlanta Injury Law offers essential public safety and legal advice for car accident victims in Georgia, emphasizing immediate steps that can significantly impact health outcomes and insurance claim success.

August 29, 2025
Oncotelic Therapeutics Highlights Robust Oncology Pipeline and CEO's Patent Portfolio

Oncotelic Therapeutics Highlights Robust Oncology Pipeline and CEO's Patent Portfolio

Oncotelic Therapeutics showcases its clinical-stage oncology and immunotherapy pipeline, including multiple late-stage candidates and rare disease programs, while emphasizing CEO Dr. Vuong Trieu's extensive intellectual property contributions that underpin the company's competitive strategy.

August 28, 2025
Lantern Pharma Unveils AI Module to Predict Cancer Treatment Efficacy

Lantern Pharma Unveils AI Module to Predict Cancer Treatment Efficacy

Lantern Pharma has developed an artificial intelligence module that enhances predictive capabilities for cancer drug combinations, potentially accelerating personalized oncology treatments and improving clinical success rates.

August 28, 2025
New PREVENT Equations Transform Cardiovascular Risk Assessment and Personalize Hypertension Treatment

New PREVENT Equations Transform Cardiovascular Risk Assessment and Personalize Hypertension Treatment

The American Heart Association's PREVENT equations provide more accurate cardiovascular disease risk predictions, enabling personalized treatment decisions for adults with high blood pressure while addressing concerns about overtreatment.

August 28, 2025
Izotropic Corporation Integrates AI Algorithm into Breast CT Imaging System to Enhance Clinical Efficiency

Izotropic Corporation Integrates AI Algorithm into Breast CT Imaging System to Enhance Clinical Efficiency

Izotropic Corporation has integrated a proprietary AI-based machine-learning reconstruction algorithm into its IzoView Breast CT Imaging System, developed with Johns Hopkins University, to improve image quality while maintaining low radiation doses and addressing workflow limitations of conventional methods.

August 28, 2025
HeartBeam's Portable ECG Device Enables Hospital-Level Cardiac Monitoring Outside Clinical Settings

HeartBeam's Portable ECG Device Enables Hospital-Level Cardiac Monitoring Outside Clinical Settings

HeartBeam's credit-card-sized FDA-cleared device synthesizes 12-lead ECGs from 3D signals, potentially transforming remote cardiac care by providing on-demand arrhythmia evaluation and integration with automated interpretation software.

August 28, 2025
Tropic Air Rescue Fills Critical Gap in Bahamas Emergency Services with Private Helicopter Ambulance Program

Tropic Air Rescue Fills Critical Gap in Bahamas Emergency Services with Private Helicopter Ambulance Program

Anthony Marinello's launch of Tropic Air Rescue addresses the complete absence of helicopter air ambulance services in the Bahamas, providing critical emergency medical transport through an innovative membership model that bridges a dangerous healthcare gap.

August 28, 2025
PreviousPage 36 of 79Next